DE69115687T2 - Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese - Google Patents
Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch IontophoreseInfo
- Publication number
- DE69115687T2 DE69115687T2 DE69115687T DE69115687T DE69115687T2 DE 69115687 T2 DE69115687 T2 DE 69115687T2 DE 69115687 T DE69115687 T DE 69115687T DE 69115687 T DE69115687 T DE 69115687T DE 69115687 T2 DE69115687 T2 DE 69115687T2
- Authority
- DE
- Germany
- Prior art keywords
- fatty acids
- iontophoresis
- medicament
- administration
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51050290A | 1990-04-18 | 1990-04-18 | |
PCT/US1991/002569 WO1991016077A1 (en) | 1990-04-18 | 1991-04-15 | Improved method to administer drugs by iontophoresis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69115687D1 DE69115687D1 (de) | 1996-02-01 |
DE69115687T2 true DE69115687T2 (de) | 1996-07-18 |
Family
ID=24031010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69115687T Expired - Lifetime DE69115687T2 (de) | 1990-04-18 | 1991-04-15 | Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0525063B1 (de) |
JP (1) | JP3261501B2 (de) |
AT (1) | ATE131733T1 (de) |
AU (1) | AU650879B2 (de) |
CA (1) | CA2078998A1 (de) |
DE (1) | DE69115687T2 (de) |
DK (1) | DK0525063T3 (de) |
ES (1) | ES2081476T3 (de) |
FI (1) | FI924724A (de) |
GR (1) | GR3018883T3 (de) |
IE (1) | IE73245B1 (de) |
NO (1) | NO924029D0 (de) |
NZ (1) | NZ237489A (de) |
PT (1) | PT97410B (de) |
WO (1) | WO1991016077A1 (de) |
ZA (1) | ZA912192B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002232A1 (en) * | 1994-07-13 | 1996-02-01 | Alza Corporation | Composition and method for enhancing transdermal electrotransport agent delivery |
US5985316A (en) * | 1995-04-28 | 1999-11-16 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US5990179A (en) * | 1995-04-28 | 1999-11-23 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US6757560B1 (en) | 1999-04-09 | 2004-06-29 | Novosis Pharma Ag | Transdermal delivery system (TDS) with electrode network |
DE19816143A1 (de) | 1998-04-09 | 1999-10-21 | Fischer Wilfried | Transdermales Applikationssystem (TDS) mit Elektrodenraster |
ATE366601T1 (de) | 2003-03-12 | 2007-08-15 | Novosis Ag | Transdermales wirkstoffverabreichungssystem mit elektrodenraster |
DE102007020799A1 (de) | 2007-05-03 | 2008-11-06 | Novosis Ag | Transdermales therapeutisches System mit Remifentanil |
DE102007021549A1 (de) | 2007-05-08 | 2008-11-13 | Novosis Ag | Transdermales therapeutisches System enthaltend mindestens zwei Opioide |
DE102007058504A1 (de) | 2007-12-05 | 2009-07-09 | Acino Ag | Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR) |
DE102010024558B4 (de) | 2010-06-22 | 2016-04-21 | Amw Gmbh | Transdermales therapeutisches System mit Elektroden |
CN115436538B (zh) * | 2022-09-17 | 2023-08-01 | 山东省计量科学研究院 | 一种肉类食品基体兽药残留标准物质制备装置与方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
JPH02503672A (ja) * | 1987-06-01 | 1990-11-01 | ワーナー‐ランバート・コンパニー | 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル |
EP0351897A3 (de) * | 1988-06-17 | 1990-03-21 | The Procter & Gamble Company | Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze |
-
1991
- 1991-03-19 NZ NZ237489A patent/NZ237489A/en unknown
- 1991-03-22 ZA ZA912192A patent/ZA912192B/xx unknown
- 1991-04-15 DK DK91908337.8T patent/DK0525063T3/da active
- 1991-04-15 AT AT91908337T patent/ATE131733T1/de not_active IP Right Cessation
- 1991-04-15 JP JP50804791A patent/JP3261501B2/ja not_active Expired - Lifetime
- 1991-04-15 EP EP91908337A patent/EP0525063B1/de not_active Expired - Lifetime
- 1991-04-15 DE DE69115687T patent/DE69115687T2/de not_active Expired - Lifetime
- 1991-04-15 ES ES91908337T patent/ES2081476T3/es not_active Expired - Lifetime
- 1991-04-15 CA CA002078998A patent/CA2078998A1/en not_active Abandoned
- 1991-04-15 AU AU77500/91A patent/AU650879B2/en not_active Expired
- 1991-04-15 WO PCT/US1991/002569 patent/WO1991016077A1/en active IP Right Grant
- 1991-04-17 IE IE128091A patent/IE73245B1/en not_active IP Right Cessation
- 1991-04-18 PT PT97410A patent/PT97410B/pt not_active IP Right Cessation
-
1992
- 1992-10-16 NO NO924029A patent/NO924029D0/no unknown
- 1992-10-19 FI FI924724A patent/FI924724A/fi not_active Application Discontinuation
-
1996
- 1996-02-01 GR GR960400277T patent/GR3018883T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0525063B1 (de) | 1995-12-20 |
ATE131733T1 (de) | 1996-01-15 |
GR3018883T3 (en) | 1996-05-31 |
IE73245B1 (en) | 1997-05-21 |
CA2078998A1 (en) | 1991-10-19 |
AU7750091A (en) | 1991-11-11 |
AU650879B2 (en) | 1994-07-07 |
IE911280A1 (en) | 1991-10-23 |
NO924029L (no) | 1992-10-16 |
WO1991016077A1 (en) | 1991-10-31 |
NZ237489A (en) | 1995-07-26 |
PT97410B (pt) | 1998-08-31 |
NO924029D0 (no) | 1992-10-16 |
DE69115687D1 (de) | 1996-02-01 |
FI924724A0 (fi) | 1992-10-19 |
EP0525063A1 (de) | 1993-02-03 |
ZA912192B (en) | 1992-01-29 |
PT97410A (pt) | 1992-01-31 |
DK0525063T3 (da) | 1996-01-29 |
JP3261501B2 (ja) | 2002-03-04 |
JPH05506232A (ja) | 1993-09-16 |
ES2081476T3 (es) | 1996-03-16 |
FI924724A (fi) | 1992-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE122899T1 (de) | Verfahren und gegenstand zur transdermalen administration von dexmedetomidin. | |
SE8703625D0 (sv) | New medical use | |
SE8404243L (sv) | Forfarande och anordning for elektro-terapeutisk behandling | |
DE3587941T2 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
DE3884081D1 (de) | Anti-Akne-Zusammensetzung. | |
SE9401406L (sv) | Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma | |
ATE40525T1 (de) | Vorrichtung zur physiologischen frequenzsteuerung eines mit einer reizelektrode versehenen herzschrittmachers. | |
DE3585618D1 (de) | Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns. | |
ATE119772T1 (de) | Bilobalid zur anwendung als therapeutischer wirkstoff. | |
DK581685A (da) | Transderimalt system for timolol-indgift | |
DE69115687D1 (de) | Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese | |
DE59603597D1 (de) | Therapeutische zubereitung zur transdermalen applikation von wirkstoffen durch die haut | |
DE3667610D1 (de) | System zur verabreichung von substanzen durch die haut. | |
PT87345A (pt) | Processo para a fabricacao de um emplastro para a administracao controlada de substancias activas a pele | |
FI95653C (fi) | Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
DE69110615D1 (de) | Verwendung von Aminosäuren zum Schutz von ischemischem Herzgewebe und dessen metabolischer Wiederherstellung. | |
DK131586A (da) | Transdermalt, antiallergisk, farmaceutisk praeparat | |
ATE86105T1 (de) | Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie. | |
ATE28384T1 (de) | Medizinisches verfahren und zubereitung. | |
ATE48531T1 (de) | Verfahren zum sterilisieren von rekombinantem mikroorganismus. | |
ATE64539T1 (de) | Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung. | |
ATE58831T1 (de) | Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea. | |
UA28769A (uk) | Спосіб лікування променевих ушкоджень шкіри | |
DE3579642D1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |